{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:12:29Z","timestamp":1789135949029,"version":"build-2803163510"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Tacrolimus (TAC) is extensively distributed in blood cells, and the total blood concentration (Ctot) may overestimate pharmacologically active exposure, particularly in inflammatory conditions. We explored the association between TAC concentration adjusted for hematocrit (%) and lymphocyte count (Cadj) and clinical outcomes in patients with dermatomyositis-associated interstitial lung disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients in whom TAC therapy was initiated were stratified into 3 groups according to the Cadj\/Ctot ratio. The association between exacerbation of ILD and acute kidney injury [AKI] was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 23 patients were included, and 7, 7, and 9 were stratified into the low, intermediate, and high Cadj\/Ctot ratio groups, respectively. There was exacerbation of ILD in 57% and 12.5% of patients in the low and intermediate\/high Cadj\/Ctot ratio groups, respectively (odds ratio, 8.2; 95% confidence interval, 0.78\u2013134;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.045). There was AKI in 44% and 28.5% of patients in the high and low\/intermediate Cadj\/Ctot ratio groups, respectively; however, the difference was not statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Cadj-based therapeutic drug monitoring may more accurately reflect clinical outcomes than conventional Ctot-based monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001492","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:00:16Z","timestamp":1781611216000},"page":"676-679","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Hematocrit- and Lymphocyte-Adjusted Tacrolimus Concentration and Clinical Outcomes in Dermatomyositis-Associated Interstitial Lung Disease: A Short Communication"],"prefix":"10.1097","volume":"48","author":[{"given":"Ayako","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikihiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikko","family":"Sakaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11095-018-2551-x","article-title":"Pharmacokinetic and pharmacodynamic considerations for drugs binding to Alpha-1-acid glycoprotein","volume":"36","author":"Smith","year":"2018","journal-title":"Pharm Res"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/bcp.14292","article-title":"Unexpected overdose blood concentration of tacrolimus: keep in mind the role of inflammation","volume":"86","author":"Bonneville","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1365-2125.2003.02008.x","article-title":"Factors affecting variability in distribution of tacrolimus in liver transplant recipients","volume":"57","author":"Zahir","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00228-013-1584-7","article-title":"Importance of hematocrit for a tacrolimus target concentration strategy","volume":"70","author":"St\u00f8rset","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0009-9236(95)90153-1","article-title":"Pharmacokinetics of tacrolimus in liver transplant patients","volume":"57","author":"Jusko","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"R6-20260911","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/bcp.15953","article-title":"Development of a predictive model for nephrotoxicity during tacrolimus treatment using machine learning methods","volume":"90","author":"Noda","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/1756-185X.13414","article-title":"Efficacy and safety of oral high-trough level tacrolimus in acute\/subacute interstitial pneumonia with dermatomyositis","volume":"22","author":"Suzuka","year":"2019","journal-title":"Int J Rheum Dis"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:00:35Z","timestamp":1789135235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001492","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"2026-01-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}